Transaction · 0001193125-26-436131

Marantz Jing L.

Marantz Jing L., EVP, CMO, reported a transaction classified as grant at Intellia Therapeutics, Inc. involving 199822.000000 shares for an estimated $0.00. Reported holdings after the transaction were 199822.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code AEVP, CMO
NTLAIntellia Therapeutics, Inc.
Trade date
Oct 26, 2026
Filing date
Oct 28, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded199k$0.00 per share
Holdings after199kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

NTLA price since this filing

Daily closing prices, with the filing date and available return windows
NTLA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.3%1w ago -5.7%1d ago -8.7%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001193125-26-436131
Common Stock
Transaction date
Oct 26, 2026
Filed Oct 28, 2026, 08:06 PM · 2d delay
Shares
199,822 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
199,822 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score

-12 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • grant_or_award-22 points

    transaction_code = A

    Grant or award transactions are scheduled compensation, not discretionary.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

  2. F2

    This option was granted on October 26, 2026 with respect to shares of Common Stock, with 33% vesting on October 26, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments th…

Original filing · 0001193125-26-436131
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

NTLA